Lifevantage Corp (LFVN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Lifevantage Corp.
Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|
1 | $10.9 | $10.9 | $10.9 | $9.16 | 19% |
The Trend in the Analyst Price Target
LFVN's average price target has moved down $1.6 over the prior 7 days.
LFVN Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2 | 0 | 0 | 1 | 0 | 0 | 1 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LFVN as an investment opportunity.
- The number of analysts covering the stock of LFVN is greater than just about none of of all US stocks.
- LFVN has a less variance in analysts' estimates than almost 100% of all US stocks.
- LFVN has a higher average analyst price target than 19.39% of Consumer Defensive stocks.
- LFVN has a greater upside potential (average analyst target price relative to current price) than 24.22% of Pharmaceutical Products stocks.
- The NA of LFVN is higher than just about none of of all US stocks.
Stocks similar to Lifevantage Corp in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TLGT, CYCN and BLCM.
Is LFVN a Buy, Hold or Sell? See the POWR Ratings now!